Trials is an open access, peer-reviewed, online journal that encompasses all aspects of the performance and findings of randomized controlled trials. We publish articles on general trial methodology as well as protocols, commentaries and traditional results papers - regardless of outcome or significance of findings.
Editors-in-Chief
- Doug Altman, University of Oxford
- Curt Furberg, Wake Forest University of Medicine
- Jeremy Grimshaw, Ottawa Health Research Institute
- Peter Rothwell, University of Oxford
Articles
-
Study protocol
-
Study protocol
-
Study protocol
-
Study protocol
- View more articles
Latest from the ISRCTN Register
Meetings and Events
You may be interested in one of these upcoming events:
- ACRP's 2013 Global Conference & Exhibition 13th - 16th April, Orlando, Florida
- SCT 34th Annual Meeting May 19th - 22nd Boston, Massachusetts
- 2nd Annual Cancer Immunotherapy Conference April 4-5, Washington, DC
AllTrials campaign
Trials supports the AllTrials initiative, campaigning for the registration of all trials past and present, and the reporting of full methods and the results of all trials.
Editor's profile
Curt D. Furberg
Professor Curt D. Furberg is a co-Editor-in-Chief of Trials. He is a Professor of Public Health at Wake Forest University Health Sciences, where he has been since 1986. Professor Furberg earned his MD in Sweden in 1963 and has worked at the Minneapolis LRC Clinic as the Chief of the Clinical Trials Branch and the Clinical Trials Research Branch of the National Heart, Lung, and Blood Institute - where he was the Associate Director for the Clinical Applications and Prevention Program. In addition, Professor Furberg is a nationally and internationally recognized expert on the design, conduct, analysis and monitoring of clinical trials. He has worked closely with investigators at the NIH and several pharmaceutical companies and is also a world-renowned cardiovascular epidemiologist with special expertise in lipid-lowering and blood pressure-lowering therapies. He is a strong proponent for evidence-based medicine, and his public health background provides a strong foundation for his views on drug evaluation and patient safety.
Email updates
Receive periodic news and updates relating to this journal straight to your inbox.
Indexed by
- CAS
- Current contents
- Embase
- Index Copernicus
- MEDLINE
- PubMed
- PubMed Central
- Science Citation Index Expanded
- Scopus







RSS
Comments
View more comments